West Pharmaceutical Services EBIT 2010-2024 | WST

West Pharmaceutical Services EBIT for the quarter ending December 31, 2024 was $0.160B, a 0.81% decline year-over-year.

  • West Pharmaceutical Services 2024 EBIT was 0.57B, a 15.7% decline from 2023.
  • West Pharmaceutical Services 2023 EBIT was 0.676B, a 7.9% decline from 2022.
  • West Pharmaceutical Services 2022 EBIT was 0.734B, a 2.43% decline from 2021.

EBIT can be defined as earnings before interest and taxes.

West Pharmaceutical Services EBIT 2010-2024 | WST

  • West Pharmaceutical Services 2024 EBIT was 0.57B, a 15.7% decline from 2023.
  • West Pharmaceutical Services 2023 EBIT was 0.676B, a 7.9% decline from 2022.
  • West Pharmaceutical Services 2022 EBIT was 0.734B, a 2.43% decline from 2021.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$75.6B
Becton Dickinson (BDX)$65.4B
Cardinal Health (CAH)$30.8B
Straumann Holding AG (SAUHY)$23.4B
Labcorp (LH)$20.8B
Cooper (COO)$17.7B
Align Technology (ALGN)$14.8B
Henry Schein (HSIC)$9.7B
Merit Medical Systems (MMSI)$6.2B
DENTSPLY SIRONA (XRAY)$3.8B
Patterson (PDCO)$2.7B
CONMED (CNMD)$1.9B
STAAR Surgical (STAA)$830M
Lifevantage (LFVN)$211M
Pro-Dex (PDEX)$109M